Methylphenidate Hydrochloride
Product Images NDC 57664-608

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Methylphenidate Hydrochloride (NDC 57664-608). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Methylphenidate 01)

Chemical structure diagram of Methylphenidate Hydrochloride showing its molecular composition, including a phenyl group, ester linkage, piperidine ring, and associated hydrochloride salt.*

FDA Label Image

Figure 1 (Methylphenidate 02)

A pharmacokinetic line graph comparing mean plasma methylphenidate concentration (ng/mL) over time (hours) for two dosing regimens: Methylphenidate Hydrochloride Extended-Release Tablets 18 mg once daily and Methylphenidate 5 mg three times daily. The graph shows concentration trends from 0 to 32 hours.*

FDA Label Image

Figure 2 (Methylphenidate 03)

Bar chart comparing maximum symptoms on the Inattention/Overactivity Scale between Methylphenidate Hydrochloride Extended-Release Tablets once daily and placebo groups across three studies. The vertical axis ranges from no symptoms to a maximum of 15 symptoms. Study 1, Study 2, and Study 3 (Week 4) all show lower symptom scores for the Methylphenidate group versus placebo, with sample sizes indicated at the bottom of each bar.*

FDA Label Image

Figure 3 (Methylphenidate 04)

A line graph comparing attention levels over 12 hours post initial dose between Methylphenidate Extended-Release Tablets once daily and placebo. The y-axis measures combined attention subscale from more attentive to less attentive, showing Methylphenidate maintains higher attention compared to placebo.*

FDA Label Image

Pdp-18mg (Methylphenidate 05)

Label for Methylphenidate Hydrochloride Extended-Release Tablets USP 18 mg by Sun Pharmaceutical Industries, Inc. The label indicates it contains 100 tablets, is for prescription use only, and includes pharmacist dispensing instructions. The label also features the NDC number 57664-606-88 and barcode.*

FDA Label Image

Pdp-27mg (Methylphenidate 06)

Label for Methylphenidate Hydrochloride Extended-Release Tablets USP 27 mg by Sun Pharmaceutical Industries, Inc. The label indicates the strength (27 mg), extended-release tablets form, and package quantity of 100 tablets. It includes dispensing instructions and regulatory information such as the NDC number 57664-607-88 and a barcode.*

FDA Label Image

Pdp-36mg (Methylphenidate 07)

Label for Methylphenidate Hydrochloride Extended-Release Tablets, USP 36 mg by Sun Pharmaceutical Industries, Inc. The label includes dosage form as extended-release tablets, strength of 36 mg, and package quantity of 100 tablets. It also displays directions to dispense with Medication Guide, storage instructions, and manufacturer details.*

FDA Label Image

Pdp-54mg (Methylphenidate 08)

Label for Methylphenidate Hydrochloride Extended-Release Tablets, USP 54 mg by Sun Pharmaceutical Industries, Inc. The label states the product is Rx only, in a 100 tablet count. It includes storage instructions, usual dosage information, and cautions regarding use and dispensing. Two barcodes are present along with the NDC number 57664-609-88.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.